Temporal requirements of insulin/IGF-1 signaling for proteotoxicity protection
2010

Insulin Signaling and Proteotoxicity in Aging

publication 10 minutes Evidence: moderate

Author Information

Author(s): Ehud Cohen, Du Deguo, Joyce Derek, Kapernick Erik A, Volovik Yuli, Kelly Jeffery W, Dillin Andrew

Primary Institution: Howard Hughes Medical Institute, Glenn Center for Aging Research, The Salk Institute for Biological Studies

Hypothesis

Can late-life reduction of insulin/IGF-1 signaling protect against proteotoxicity without affecting lifespan?

Conclusion

Reducing insulin/IGF-1 signaling late in life can protect against proteotoxicity associated with Alzheimer's disease without extending lifespan.

Supporting Evidence

  • Late-life insulin/IGF-1 signaling reduction protects against Aβ toxicity.
  • DAF-16 and HSF-1 are critical for the protective effects of reduced insulin signaling.
  • Insulin signaling reduction can lead to the formation of less toxic protein aggregates.

Takeaway

This study found that lowering certain signals in older worms can help protect them from harmful protein buildup, which is linked to diseases like Alzheimer's.

Methodology

Transgenic nematodes expressing human Aβ were used to study the effects of insulin/IGF-1 signaling reduction on proteotoxicity.

Limitations

The study primarily focuses on a model organism, which may not fully represent human biology.

Participant Demographics

Transgenic nematodes (Caenorhabditis elegans) were used in the study.

Statistical Information

P-Value

3.55E-09

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1111/j.1474-9726.2009.00541.x

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication